Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Worthington Enterprises (WOR) Lags Q1 Earnings and Revenue Estimates
Worthington Enterprises (WOR) Lags Q1 Earnings and Revenue Estimates

Worthington Enterprises (WOR) came out with quarterly earnings of $0.74 per share, missing the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.5 per share a year ago

MillerKnoll (MLKN) Beats Q1 Earnings and Revenue Estimates
MillerKnoll (MLKN) Beats Q1 Earnings and Revenue Estimates

MillerKnoll (MLKN) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.36 per share a year ago. These

AAR (AIR) Surpasses Q1 Earnings and Revenue Estimates
AAR (AIR) Surpasses Q1 Earnings and Revenue Estimates

AAR (AIR) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.85 per share a year ago. These figures are

Micron (MU) Tops Q4 Earnings and Revenue Estimates
Micron (MU) Tops Q4 Earnings and Revenue Estimates

Micron (MU) came out with quarterly earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $1.18 per share a year ago. These figures are

Top Analyst Reports for Apple, Eli Lilly & Chevron
Top Analyst Reports for Apple, Eli Lilly & Chevron

Tuesday, September 23, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple

What's Going On With NVIDIA and OpenAI?Photo, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
What's Going On With NVIDIA and OpenAI?

The AI frenzy continues to dominate headlines, with poster-child NVIDIA NVDA at the forefront yet again.

But why?

NVIDIA unveiled a strategic partnership to deploy at least 10 gigawatts of NVIDIA

Trumps PQC Push Could Boost IBM, Google, NVIDIA & Quantum Pure PlaysPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/da273d82-9e59-413a-99b3-2b0094ff0854.png
Trumps PQC Push Could Boost IBM, Google, NVIDIA & Quantum Pure Plays

The Trump administration’s renewed quantum policy push through executive actions and the likely reauthorization of the National Quantum Initiative Act (NQIA) could significantly benefit both

NVIDIA & 2 Profit-Rich Stocks to Watch as Nasdaq Hits MilestonePhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
NVIDIA & 2 Profit-Rich Stocks to Watch as Nasdaq Hits Milestone

The Nasdaq broke records on Monday, reaching an all-time intraday high. The tech-heavy index also closed the trading session at a record high, finishing at 22,788.98. Hence, it’s judicious for

The Best Momentum Stocks to Buy for OctoberPhoto, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
The Best Momentum Stocks to Buy for October

The stock market is trading at new all-time highs in the final full week of September and the third quarter. The recent surge has been driven by a wave of spending across the artificial intelligence

IONS' Rare Neurological Disease Drug Meets Late-Stage Study GoalPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
IONS' Rare Neurological Disease Drug Meets Late-Stage Study Goal

Ionis Pharmaceuticals IONS announced positive topline results from a pivotal phase III study evaluating its investigational RNA-targeted therapy zilganersen for treating a rare neurological

Is Now the Time to Buy Small-Cap Stocks?Photo, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
Is Now the Time to Buy Small-Cap Stocks?

All major indexes hit new record highs last week after the Federal Reserve announced a 25-basis-point interest-rate cut and signaled more cuts ahead. For the small-cap Russell 2000 Index, it was the

Palantir vs. UiPath: Which AI-First Software Stock is a Better Buy?Photo, wide shot, wide-angle lens,  Software company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/70b5df15-67cc-4a1b-af41-3596614daf77.png
Palantir vs. UiPath: Which AI-First Software Stock is a Better Buy?

Both Palantir Technologies Inc. PLTR and UiPath Inc. PATH stand out as leading innovators in AI-driven software.

Palantir has built its reputation on large-scale data analytics and decision

OUT Stock Rises 16.2% in 3 Months: Will it Continue to Rise?
OUT Stock Rises 16.2% in 3 Months: Will it Continue to Rise?

OUTFRONT Media OUT shares have gained 16.2% in the past three months against the industry’s decline of 1.3%.

This New York-based real estate investment trust (REIT) enjoys a diversified portfolio of

Do Options Traders Know Something About Doximity Stock We Don't?
Do Options Traders Know Something About Doximity Stock We Don't?

Investors in Doximity, Inc. DOCS to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $90 Put had some of the highest implied volatility

Are Options Traders Betting on a Big Move in DocuSign Stock?
Are Options Traders Betting on a Big Move in DocuSign Stock?

Investors in DocuSign, Inc. DOCU need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $30 Call had some of the highest implied

Flanigan's Gains 37.7% in Six Months: How to Play the Stock?
Flanigan's Gains 37.7% in Six Months: How to Play the Stock?

Flanigan's Enterprises, Inc. BDL investors have been experiencing some short-term gains from the stock lately, despite its bumpy ride over recent months. Shares of the owners and operators of the

SouthState Stock Rises 11.6% in 3 Months: Is It Worth Betting On?
SouthState Stock Rises 11.6% in 3 Months: Is It Worth Betting On?

SouthState Corporation’s SSB  shares have rallied 11.6% in the past three months, outperforming the industry’s growth of 6.8%. Further, the company has performed better than its peers, Origin

SoFi vs. Nu Holdings: Which Fintech Stock Stands Out Right Now?
SoFi vs. Nu Holdings: Which Fintech Stock Stands Out Right Now?

Fintech has become one of the most closely watched areas in financial markets, with SoFi Technologies SOFI and Nu Holdings NU standing out as notable players. SoFi has expanded from student loan

ZTO Express Down 18.7% Y/Y: Will the Plunge Continue Throughout 2025?
ZTO Express Down 18.7% Y/Y: Will the Plunge Continue Throughout 2025?

Shares of ZTO Express (ZTO) have had an unimpressive run in a year. Shares of this company have plunged 18.7% in the same period, underperforming the transportation-services industry’s14.5% decline.

Popular Stock Touches 52-Week High: Should You Consider Investing?
Popular Stock Touches 52-Week High: Should You Consider Investing?

Shares of Popular, Inc. BPOP touched a new 52-week high of $128.89 in yesterday's trading session. However, the stock closed the session a little lower at $126.98.

Over the past six months, BPOP

FIG's Expanding Portfolio Fuel Revenue Growth: A Sign of More Upside?
FIG's Expanding Portfolio Fuel Revenue Growth: A Sign of More Upside?

Figma FIG is benefiting from its expanding product portfolio, which has contributed to its revenue growth and positions the company for further upside. In the second quarter of 2025, Figma achieved

Skin in the Game: The US Government & Nvidia Back IntelPhoto, wide shot, wide-angle lens,  Cloud computing provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/893880f6-c6d9-4518-b1a0-f0be05207ac4.png
Skin in the Game: The US Government & Nvidia Back Intel

Intel Company Overview

Zacks Rank #3 (Hold) stock Intel (INTC) designs and manufactures a plethora of computer hardware and software products for individuals and businesses. Founded in 1968, the

SL Green, PGIM Boost Strength With Refinancing of 11 Madison AvenuePhoto, wide shot, wide-angle lens,  Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png
SL Green, PGIM Boost Strength With Refinancing of 11 Madison Avenue

SL Green Realty Corp. SLG, with its joint venture partner, PGIM, recently announced completion of a $1.4 billion, five-year, fixed-rate refinancing of 11 Madison Avenue.

The new mortgage carries a

BE vs. PLUG: Which Fuel-Cell Stock Has More Growth Potential?
BE vs. PLUG: Which Fuel-Cell Stock Has More Growth Potential?

The companies operating in the Zacks Alternate Energy- Other industry are becoming increasingly important as nations strive to reduce reliance on fossil fuels and lower emissions from electricity

STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic SystemPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System

Stereotaxis STXS recently announced that physicians at Erasmus University Medical Center in Rotterdam successfully performed the first procedures in the Netherlands using its Genesis Robotic